Clinical use of a pronuclear stage score following intracytoplasmic sperm injection: impact on pregnancy rates under the conditions of the German embryo protection law

Citation
M. Ludwig et al., Clinical use of a pronuclear stage score following intracytoplasmic sperm injection: impact on pregnancy rates under the conditions of the German embryo protection law, HUM REPR, 15(2), 2000, pp. 325-329
Citations number
22
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
HUMAN REPRODUCTION
ISSN journal
02681161 → ACNP
Volume
15
Issue
2
Year of publication
2000
Pages
325 - 329
Database
ISI
SICI code
0268-1161(200002)15:2<325:CUOAPS>2.0.ZU;2-5
Abstract
The German embryo protection law does not allow embryo selection, but only selection of pronuclear stage (PN) oocytes, Only as many PN oocytes are all owed to be selected as are planned to be transferred. Therefore, a clinical ly applicable score to assess the quality of PN oocytes would be helpful. A recently published score was used under the conditions of the German embry o protection law in 74 non-selected, consecutive intracytoplasmic sperm inj ection cycles. Only criteria which could be evaluated at the PN stage were included, i.e. not criteria which could only be assessed after pronuclear m embrane breakdown or the first cleavage division. Supernumerary PN oocytes were cryopreserved after selection. A mean PN score of <13 (sum of scores o f all selected PN oocytes/number of selected PN oocytes) led to a pregnancy rate of 4%, a mean PN score of greater than or equal to 13 to a pregnancy rate of 22%. Embryo morphology and cumulative PN were correlated (r = 0.52, P < 0.05). The negative predictive value was 92% at a threshold of 13 for the mean PN score. The use of this and perhaps additional scoring systems o f PN stage oocytes might help to offer patients in Germany the transfer of two selected PN oocytes, which would reduce the multiple pregnancy rate.